Stock search

Ticker or company name

Compare stocks

Market: US

  • WSTWest Pharmaceutical Services

Add stock

Ticker or company

Summary

WST
West Pharmaceutical Services
$417,80Up +0,33%
Year: Up +56%
83/100Ratio would consider buying
Open stock page

Traffic light — 10 checks

CheckWST7 ✓ 1 — 1 ✕
P/E vs its history45,5
P/E vs industry45,5
Forward P/E40,5
Revenue growth, YoY+12,6%
EPS growth, YoY+32,0%
Net margin18,8%
Net debt / EBITDA−0,3
Free cash flow$453 m
Share count over a year−2,5%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterWSTTTMIndustry medianTTM
P/E TTM ↓45,537,9
Forward P/E ↓40,529,5
PEG ↓2,63,7
P/S TTM ↓8,66,6
EV/EBITDA ↓30,029,9
P/FCF ↓64,238,7

Price, %

  • WSTn/a

Returns

Best WorstNo mark — in between

PeriodWST
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

WST
Share of “buy”95%
Beat the forecast4 of 4
Average “surprise”+17,2%
Insiders over 12 monthssales $6,57 m

Details are on each stock page.